Anti-aging drugs market set to reach $91.23B by 2030

By AI, Created 10:34 AM UTC, May 20, 2026, /AGP/ – The global anti-aging drugs market is projected to rise from $60.81 billion in 2025 to $65.51 billion in 2026, with growth expected to continue to $91.23 billion by 2030. Rising demand from aging populations, wellness spending and advances in treatment options are driving the outlook, with North America holding the largest share in 2025.

Why it matters: - The anti-aging drugs market is growing alongside a larger older population and rising interest in longer, healthier lifespans. - The category includes drugs and supplements aimed at slowing or reversing aging processes and addressing age-related diseases. - Demand is tied to healthcare costs, wellness spending and the expanding market for preventive treatments.

What happened: - The Business Research Company released its Anti-Aging Drugs Global Market Report 2026, covering market size, trends and a forecast through 2035. - The report puts the market at $60.81 billion in 2025. - The market is projected to reach $65.51 billion in 2026, a 7.7% increase. - The report forecasts growth to $91.23 billion by 2030, at a 8.6% CAGR. - North America held the largest share of the market in 2025. - The report also covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - A free sample and full report are available via the company’s sample page and the full market report.

The details: - Market growth has been driven by a rising elderly population, heightened awareness of skin aging, a growing wellness and beauty industry, wider availability of anti-aging supplements and advances in dermatological treatments. - Future growth is expected to come from technological integration into anti-aging therapies, demand for personalized medicine, expansion of home-based treatments, growth in the nutraceutical sector and more investment in stem cell and regenerative therapies. - The report highlights personalized anti-aging solutions, natural and plant-derived ingredients, nutraceuticals, minimally invasive delivery systems and preventive health as major trends. - Anti-aging treatments are designed to preserve youthful characteristics and improve quality of life. - The Population Reference Bureau said in January 2024 that the number of Americans aged 65 and older is expected to rise from 58 million in 2022 to 82 million by 2050. - That would lift the U.S. 65-and-older population share from 17% to 23%.

Between the lines: - The forecast suggests anti-aging is shifting from a beauty-led category toward a broader health-and-longevity market. - The strongest opportunities appear to be in products that combine preventive care, personalization and less invasive delivery. - North America’s lead points to early adoption, stronger spending power and a larger base of older consumers.

What’s next: - The report expects the market to keep expanding through 2030 as aging demographics and longevity-focused consumer demand increase. - Growth will likely depend on how quickly new therapies move from specialty use into more mainstream preventive care. - The company also points readers to related reports on anti-Parkinson drugs, anti-jamming and Alzheimer’s drugs.